The effect of high intensity focused ultrasound treatment on metastases in a murine melanoma model.

This study aims to assess the risk of high intensity focused ultrasound (HIFU) therapy on the incidence of distant metastases and to investigate its association with HIFU-elicited anti-tumor immunity in a murine melanoma (B16-F10) model. Tumor-bearing legs were amputated immediately after or 2 days following HIFU treatment to differentiate the contribution of the elicited anti-tumor immunity. In mice undergoing amputation immediately after mechanical, thermal, or no HIFU treatment, metastasis rates were comparable (18.8%, 13.3%, and 12.5%). In contrast, with a 2-day delay in amputation, the corresponding metastasis rates were 6.7%, 11.8%, and 40%, respectively. Animal survival rate was higher and CTL activity was enhanced in the HIFU treatment groups. Altogether, our results suggest that HIFU treatment does not increase the risk of distant metastasis. Instead, HIFU treatment can elicit an anti-tumor immune response that may be harnessed to improve the overall effectiveness and quality of cancer therapy.

[1]  J. Schalken,et al.  Influence of high-intensity focused ultrasound on the development of metastases. , 1997, European urology.

[2]  Wen-zhi Chen,et al.  Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound. , 2004, Ultrasound in medicine & biology.

[3]  J. Werner,et al.  Clinical patterns of metastasis , 2006, Cancer and Metastasis Reviews.

[4]  Pei Zhong,et al.  Investigation of HIFU-induced anti-tumor immunity in a murine tumor model , 2007, Journal of Translational Medicine.

[5]  D. Jenkins,et al.  Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis , 2004, Clinical & Experimental Metastasis.

[6]  I. Fidler,et al.  Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.

[7]  J. Kennedy.  High-intensity focused ultrasound in the treatment of solid tumours , 2005, Nature Reviews Cancer.

[8]  F. Fry,et al.  Tumor irradiation with intense ultrasound. , 1978, Ultrasound in medicine & biology.

[9]  Douglas L. Miller,et al.  The potential for enhancement of mouse melanoma metastasis by diagnostic and high-amplitude ultrasound. , 2006, Ultrasound in medicine & biology.

[10]  Wen-zhi Chen,et al.  Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. , 2004, Ultrasound in medicine & biology.

[11]  F. Fry,et al.  Effects of high-intensity focused ultrasound in the treatment of experimental neuroblastoma. , 1992, Journal of pediatric surgery.

[12]  Moses Rodriguez,et al.  Immunotherapeutic Potential of B7-DC (PD-L2) Cross-Linking Antibody In Conferring Antitumor Immunity , 2004, Cancer Research.

[13]  Wen-zhi Chen,et al.  A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer , 2003, British Journal of Cancer.

[14]  P. Meaney,et al.  The intensity dependence of lesion position shift during focused ultrasound surgery. , 2000, Ultrasound in medicine & biology.

[15]  Yunbo Liu,et al.  Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. , 2005, Biochemical and biophysical research communications.

[16]  S. Lyons.  Advances in imaging mouse tumour models in vivo , 2005, The Journal of pathology.

[17]  Feng Wu,et al.  Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment. , 2008, Ultrasound in medicine & biology.

[18]  D. Chopin,et al.  Antitumoral local effect and metastatic risk of focused extracorporeal pyrotherapy on Dunning R-3327 tumors. , 1996, European urology.

[19]  David K. Stevenson,et al.  Bioluminescent indicators in living mammals , 1998, Nature Medicine.

[20]  J. Mulé,et al.  Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. , 2001, Cancer research.

[21]  Daniel E. Hall,et al.  Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. , 2000, Neoplasia.